Standard Biotools (LAB) Cash & Equivalents (QoQ) (2010 - 2026)
Standard Biotools (LAB) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60% |
| Mar 31, 2026 | 119.90% |
| Dec 31, 2025 | -6.61% |
| Sep 30, 2025 | -18.41% |
| Jun 30, 2025 | 3.35% |
| Mar 31, 2025 | -9.09% |
| Dec 31, 2024 | -20.35% |
| Sep 30, 2024 | -21.82% |
| Jun 30, 2024 | -5.98% |
| Mar 31, 2024 | 449.24% |
| Dec 31, 2023 | -34.74% |
| Sep 30, 2023 | -43.78% |
| Jun 30, 2023 | 25.02% |
| Mar 31, 2023 | 39.03% |
| Dec 31, 2022 | 34.48% |
| Sep 30, 2022 | -18.79% |
| Jun 30, 2022 | 143.16% |
| Mar 31, 2022 | 5.20% |
| Dec 31, 2021 | -2.83% |
| Sep 30, 2021 | 2,884.74% |